Anti-PD-1/PD-L1 antibodies

DRUG2 trials

Sponsors

Chinese PLA General Hospital, Shanghai Zhongshan Hospital

Conditions

Advanced Solid TumorsHepatocellular Carcinoma

Unknown Phase

A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors

Chinese PLA General HospitalAdvanced Solid Tumors

Start: 2018-12-30End: 2019-09-30Target: 400Updated: 2019-05-16

Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC

RecruitingNCT06537908

Shanghai Zhongshan HospitalHepatocellular Carcinoma

Start: 2024-08-01End: 2029-12-31Target: 50Updated: 2025-12-15